Hunan Kelun Pharmaceutical Co., Ltd.
Clinical trials sponsored by Hunan Kelun Pharmaceutical Co., Ltd., explained in plain language.
A Chinese pharmaceutical company producing generic and innovative drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Generic cancer drug shows promise in small bioequivalence study
Knowledge-focused CompletedThis study tested whether a generic gefitinib tablet (made by Hunan Kelun) works the same as the brand-name drug Iressa in 38 healthy Chinese men. Each participant took a single dose of either the generic or brand-name drug after a meal, then switched to the other. Researchers me…
Phase: PHASE1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Healthy men test generic vs. brand drug in fasting study
Knowledge-focused CompletedThis study tested whether a generic gefitinib tablet works the same as the brand-name version (Iressa) in the body. It involved 38 healthy Chinese men who took a single dose of each under fasting conditions. The goal was to check if the two drugs are bioequivalent, meaning they p…
Phase: PHASE1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC